Current and future therapeutical approaches for COVID-19
Coronavirus 2019 (COVID-19), the WHO-classified novel coronavirus of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a global pandemic …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a global pandemic …
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
G Li, E De Clercq - Nature reviews Drug discovery, 2020 - nature.com
Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Skip to main content Thank
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
you for visiting nature.com. You are using a browser version with limited support for CSS. To …
Pathogenesis‐directed therapy of 2019 novel coronavirus disease
CW Stratton, YW Tang, H Lu - Journal of medical virology, 2021 - Wiley Online Library
The 2019 novel coronavirus disease (COVID‐19) now is considered a global public health
emergency. One of the unprecedented challenges is defining the optimal therapy for those …
emergency. One of the unprecedented challenges is defining the optimal therapy for those …
An overview of potential therapeutic agents to treat COVID-19
X Dong, Z Tian, C Shen, C Zhao - Bioscience trends, 2020 - jstage.jst.go.jp
The emerging novel coronavirus disease (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has swept across the world and become a global …
syndrome coronavirus 2 (SARS-CoV-2), has swept across the world and become a global …
Pathophysiology and potential therapeutic candidates for COVID-19: a poorly understood arena
A Samaddar, M Grover, VL Nag - Frontiers in pharmacology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19), an acute onset pneumonia caused by a novel
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …
[HTML][HTML] Therapeutic options for COVID-19: a review
R Pujari, MV Thommana, BR Mercedes, A Serwat - Cureus, 2020 - ncbi.nlm.nih.gov
An acute respiratory disease caused by a novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …
Updated approaches against SARS-CoV-2
H Li, Y Zhou, M Zhang, H Wang… - Antimicrobial agents and …, 2020 - Am Soc Microbiol
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing …
Research progress on therapeutic drugs for corona virus disease 2019.
L Yang, HQ Wang, YH Li - 2020 - cabidigitallibrary.org
Abstract Corona virus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. At present, there is no specific antiviral …
syndrome coronavirus 2 (SARS-CoV-2) infection. At present, there is no specific antiviral …
Comprehensive analysis of SARS-COV-2 drug targets and pharmacological aspects in treating the COVID-19
S Bhavaniramya, V Ramar… - Current Molecular …, 2022 - ingentaconnect.com
Corona viruses are enveloped, single-stranded RNA (Ribonucleic acid) viruses, and they
cause pandemic diseases having a devastating effect on both human healthcare and the …
cause pandemic diseases having a devastating effect on both human healthcare and the …
[PDF][PDF] Distinctive Therapeutic Strategies against Corona Virus19 (COVID-19): A Pharmacological Review.
YA Nomier, DS Rao, AH Suhaqi… - Systematic Reviews in …, 2020 - researchgate.net
Coronaviruses (CoVs) are RNA viruses threatened the global health. The causative
microorganism, causing coronavirus disease-2019 (COVID-19), is known as (novel …
microorganism, causing coronavirus disease-2019 (COVID-19), is known as (novel …